A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer.
about
Synergistic effect of combinatorial treatment with curcumin and mitomycin C on the induction of apoptosis of breast cancer cells: a cDNA microarray analysis.Ovarian cancer treatment: The end of empiricism?Comparative effectiveness of platinum-based chemotherapy versus taxane and other regimens for ovarian cancer.Systemic therapy for recurrent epithelial ovarian cancer: a clinical practice guideline.
P2860
A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
A multicenter, randomized, pha ...... inum-sensitive ovarian cancer.
@en
A multicenter, randomized, pha ...... inum-sensitive ovarian cancer.
@nl
type
label
A multicenter, randomized, pha ...... inum-sensitive ovarian cancer.
@en
A multicenter, randomized, pha ...... inum-sensitive ovarian cancer.
@nl
prefLabel
A multicenter, randomized, pha ...... inum-sensitive ovarian cancer.
@en
A multicenter, randomized, pha ...... inum-sensitive ovarian cancer.
@nl
P2093
P2860
P356
P1433
P1476
A multicenter, randomized, pha ...... inum-sensitive ovarian cancer.
@en
P2093
Andrew Berchuck
Fidel A Valea
George S Lewandowski
Larry E Puls
Lawrence R Nycum
Matthew F Kohler
Robert V Higgins
Robert W Holloway
P2860
P304
P356
10.1002/CNCR.26610
P407
P577
2011-11-09T00:00:00Z